Development of Fluorogenic Substrates of α- L -Fucosidase Useful for Inhibitor Screening and Gene-expression Profiling

Kazuki Miura, Takumi Tsukagoshi, Takako Hirano, Toshiyuki Nishio, Wataru Hakamata

Research output: Contribution to journalArticle

Abstract

Inhibitors of human α-l-fucosidases, tissue α-l-fucosidase (tFuc), and plasma α-l-fucosidase reportedly play roles in multiple diseases, suggesting their therapeutic potential for gastric disease associated with Helicobacter pylori and fucosidosis. Terminal fucose linkages on glycoproteins and glycolipids are a natural substrate for both enzymes; however, there are currently no fluorogenic substrates allowing their cellular evaluation. Here, we described the development of novel three-color fluorogenic substrates for lysosome-localized tFuc that exhibited excellent specificity and sensitivity in three human cell lines. Additionally, we developed a cell-based high-throughput inhibitor screening system in a 96-well format and a cell-based inhibitory activity evaluation system in a 6-well format for tFuc inhibitors using this substrate, which allowed accurate quantification of the inhibition rate. Moreover, analysis of significant changes in gene expression resulting from 30% inhibition of tFuc in HeLa cells revealed potential roles in gastric disease.

Original languageEnglish
JournalACS Medicinal Chemistry Letters
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Fingerprint

alpha-L-Fucosidase
Gene Expression Profiling
Fluorescent Dyes
Gene expression
Screening
Tissue
Stomach Diseases
Fucosidosis
Fucose
Glycolipids
Substrates
Lysosomes
HeLa Cells
Helicobacter pylori
Glycoproteins
Color
Cells
Throughput
Plasmas
Gene Expression

Keywords

  • DNA microarray
  • Fluorogenic substrate
  • High-throughput screening
  • Inhibitor
  • α- l -Fucosidase

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Cite this

Development of Fluorogenic Substrates of α- L -Fucosidase Useful for Inhibitor Screening and Gene-expression Profiling. / Miura, Kazuki; Tsukagoshi, Takumi; Hirano, Takako; Nishio, Toshiyuki; Hakamata, Wataru.

In: ACS Medicinal Chemistry Letters, 01.01.2019.

Research output: Contribution to journalArticle

@article{4e713852cde842c9af7707bb7074f5f5,
title = "Development of Fluorogenic Substrates of α- L -Fucosidase Useful for Inhibitor Screening and Gene-expression Profiling",
abstract = "Inhibitors of human α-l-fucosidases, tissue α-l-fucosidase (tFuc), and plasma α-l-fucosidase reportedly play roles in multiple diseases, suggesting their therapeutic potential for gastric disease associated with Helicobacter pylori and fucosidosis. Terminal fucose linkages on glycoproteins and glycolipids are a natural substrate for both enzymes; however, there are currently no fluorogenic substrates allowing their cellular evaluation. Here, we described the development of novel three-color fluorogenic substrates for lysosome-localized tFuc that exhibited excellent specificity and sensitivity in three human cell lines. Additionally, we developed a cell-based high-throughput inhibitor screening system in a 96-well format and a cell-based inhibitory activity evaluation system in a 6-well format for tFuc inhibitors using this substrate, which allowed accurate quantification of the inhibition rate. Moreover, analysis of significant changes in gene expression resulting from 30{\%} inhibition of tFuc in HeLa cells revealed potential roles in gastric disease.",
keywords = "DNA microarray, Fluorogenic substrate, High-throughput screening, Inhibitor, α- l -Fucosidase",
author = "Kazuki Miura and Takumi Tsukagoshi and Takako Hirano and Toshiyuki Nishio and Wataru Hakamata",
year = "2019",
month = "1",
day = "1",
doi = "10.1021/acsmedchemlett.9b00259",
language = "English",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - Development of Fluorogenic Substrates of α- L -Fucosidase Useful for Inhibitor Screening and Gene-expression Profiling

AU - Miura, Kazuki

AU - Tsukagoshi, Takumi

AU - Hirano, Takako

AU - Nishio, Toshiyuki

AU - Hakamata, Wataru

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Inhibitors of human α-l-fucosidases, tissue α-l-fucosidase (tFuc), and plasma α-l-fucosidase reportedly play roles in multiple diseases, suggesting their therapeutic potential for gastric disease associated with Helicobacter pylori and fucosidosis. Terminal fucose linkages on glycoproteins and glycolipids are a natural substrate for both enzymes; however, there are currently no fluorogenic substrates allowing their cellular evaluation. Here, we described the development of novel three-color fluorogenic substrates for lysosome-localized tFuc that exhibited excellent specificity and sensitivity in three human cell lines. Additionally, we developed a cell-based high-throughput inhibitor screening system in a 96-well format and a cell-based inhibitory activity evaluation system in a 6-well format for tFuc inhibitors using this substrate, which allowed accurate quantification of the inhibition rate. Moreover, analysis of significant changes in gene expression resulting from 30% inhibition of tFuc in HeLa cells revealed potential roles in gastric disease.

AB - Inhibitors of human α-l-fucosidases, tissue α-l-fucosidase (tFuc), and plasma α-l-fucosidase reportedly play roles in multiple diseases, suggesting their therapeutic potential for gastric disease associated with Helicobacter pylori and fucosidosis. Terminal fucose linkages on glycoproteins and glycolipids are a natural substrate for both enzymes; however, there are currently no fluorogenic substrates allowing their cellular evaluation. Here, we described the development of novel three-color fluorogenic substrates for lysosome-localized tFuc that exhibited excellent specificity and sensitivity in three human cell lines. Additionally, we developed a cell-based high-throughput inhibitor screening system in a 96-well format and a cell-based inhibitory activity evaluation system in a 6-well format for tFuc inhibitors using this substrate, which allowed accurate quantification of the inhibition rate. Moreover, analysis of significant changes in gene expression resulting from 30% inhibition of tFuc in HeLa cells revealed potential roles in gastric disease.

KW - DNA microarray

KW - Fluorogenic substrate

KW - High-throughput screening

KW - Inhibitor

KW - α- l -Fucosidase

UR - http://www.scopus.com/inward/record.url?scp=85072535454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072535454&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.9b00259

DO - 10.1021/acsmedchemlett.9b00259

M3 - Article

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

ER -